Brief: Implanet presents JAZZ band clinical results in hypokyphotic idiopathic scoliosis patients
Dec 6 (Reuters) - Implanet SA IMPL.PA :
* JAZZ system`s clinical validation confirms both safety and efficacy in the treatment of
hypokyphotic idiopathic scoliosis
* The study followed a 35 patient consecutive series for an average of
34 months
Source text for Eikon: ID:nBw4k2mfHa
Further company coverage: IMPL.PA
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Implanet SA
See all newsFrench orthopedic implants maker Implanet's nine-month revenue jumps, partly on strong US momentum
French and Benelux stocks-Factors to watch on September 16
France's IMPLANET H1 revenue rises on medical equipment strength, US growth
Brief: IMPLANET H1 Revenue EUR 7.1 Million
France's IMPLANET H1 revenue rises on spine implants strength, US growth